The largest holder of Ovintiv stock is BlackRock Advisors LLC, with 25.9 million shares (10.09% of the company), worth about $1.70 billion as of September 25, 2026. The 10 largest holders together own 55.7%.
In Q2 2026, 631 institutional holdings reports listed 273.0 million shares worth $13.80 billion, up 11.0% in shares from Q1 2026.
Insiders reported 35 transactions in the last two years: 6 sales worth $5.46 million and no purchases. The newest one on file is from March 13, 2026 (Eilers Meghan Nicole, General Counsel).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through March 13, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| BlackRock Advisors LLC | 25.9 million | 10.09% | $1.7B |
| Fidelity Management & Research Co. LLC | 25.7 million | 10.02% | $1.7B |
| Capital Research & Management Co. (Global Investors) | 19.4 million | 7.57% | $1.3B |
| Vanguard Portfolio Management LLC | 14.5 million | 5.63% | $949.0M |
| Vanguard Capital Management LLC | 12.6 million | 4.91% | $829.0M |
| DFA Australia Ltd. | 10.2 million | 3.95% | $666.0M |
| State Street Corporation | 10.0 million | 3.90% | $659.0M |
| T. Rowe Price International Ltd. | 9.1 million | 3.54% | $598.0M |
| Hotchkis & Wiley Capital Management LLC | 8.7 million | 3.38% | $571.0M |
| Invesco Advisers, Inc. | 7.0 million | 2.71% | $457.0M |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 631 | 273.0 million | $13.8B |
| Q1 2026 | 648 | 246.0 million | $14.6B |
| Q4 2025 | 585 | 234.0 million | $9.2B |
| Q3 2025 | 594 | 227.0 million | $9.2B |
| Q2 2025 | 585 | 226.0 million | $8.6B |
| Q1 2025 | 632 | 231.0 million | $9.9B |
| Q4 2024 | 612 | 222.0 million | $9.0B |
| Q3 2024 | 599 | 215.0 million | $8.2B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Eilers Meghan Nicole | Mar 13, 2026 | General Counsel | Sale at price 54.78 per share. | $634,462 |
| Mccracken Brendan Michael | Mar 11, 2026 | Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Code Corey Douglas | Mar 10, 2026 | Chief Financial Officer | -- | – |
| Mccracken Brendan Michael | Mar 10, 2026 | Chief Executive Officer | -- | – |
| Givens Gregory Dean | Mar 10, 2026 | Chief Operating Officer | -- | – |
| Moore Rachel Maureen | Mar 10, 2026 | Officer | -- | – |
| Eilers Meghan Nicole | Mar 10, 2026 | General Counsel | -- | – |
| Mayson Howard John | Mar 3, 2026 | Director | Sale at price 52.39 per share. | $261,950 |
| Givens Gregory Dean | Feb 27, 2026 | Chief Operating Officer | Conversion of Exercise of derivative security at price 35.80 per share. | $539,076 |
| Givens Gregory Dean | Dec 12, 2025 | Chief Operating Officer | Sale at price 40.33 per share. | $2.0M |
| Code Corey Douglas | Dec 11, 2025 | Chief Financial Officer | Conversion of Exercise of derivative security at price 32.71 - 34.63 per share. | $1.2M |
| Nance Steven Wayne | Dec 8, 2025 | Director | Sale at price 41.99 per share. | $209,950 |
Newest 12 of 35 insider transactions in the last two years.
BlackRock Advisors LLC, with 10.09% of the company (as of September 25, 2026). Next: Fidelity Management & Research Co. LLC (10.02%) and Capital Research & Management Co. (Global Investors) (7.57%).
631 institutional holdings reports listed Ovintiv shares in Q2 2026, 273.0 million shares in all worth $13.80 billion.
In the last two years insiders reported 6 sales and no purchases (35 transactions in all); the newest on file is from March 13, 2026.